Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026158
Filing Date
2021-11-10
Accepted
2021-11-10 16:15:46
Documents
52
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20210930_10q.htm   iXBRL 10-Q 957611
2 EXHIBIT 31.1 ex_277469.htm EX-31.1 13435
3 EXHIBIT 31.2 ex_277470.htm EX-31.2 13268
4 EXHIBIT 32.1 ex_277471.htm EX-32.1 6605
5 EXHIBIT 32.2 ex_277472.htm EX-32.2 6681
11 moleculinlogoresizedclear.jpg GRAPHIC 19339
  Complete submission text file 0001437749-21-026158.txt   4069463

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20210930.xsd EX-101.SCH 41028
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20210930_cal.xml EX-101.CAL 24988
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20210930_def.xml EX-101.DEF 236774
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20210930_lab.xml EX-101.LAB 237792
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20210930_pre.xml EX-101.PRE 259634
12 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20210930_10q_htm.xml XML 580072
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 211396815
SIC: 2834 Pharmaceutical Preparations